本刊中國學者近年發表論文

• 1、Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring

  Author: Yin, Weiyao; Persson, Martina; Sandin, Sven

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.1016/j.diabet.2022.101392

• 2、Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease

  Author: Mai, Ziling; Huang, Zhidong; Li, Yuqi; Xie, Yun; Li, Huanqiang; Wang, Bo; Bai, Wei; Lai, Wenguang; Yu, Sijia; Lu, Hongyu; Han, Kedong; Chen, Xuewen; Shi, Yingming; Chen, Shiqun; Liu, Jin; Liu, Yong; Chen, Jiyan

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 1, pp. -. DOI: 10.1016/j.diabet.2022.101411

• 3、Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes

  Author: Yang, Zongming; Shen, Peng; Qu, Yanlin; Xu, Lisha; Li, Tiezheng; Zhu, Zhanghang; Wu, Yonghao; Yu, Luhua; Gao, Kai; Zhang, Xinhan; Yao, Xuecheng; Meng, Lin; Lin, Hongbo; Shui, Liming; Tang, Mengling; Jin, Mingjuan; Chen, Kun; Wang, Jianbing

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 3, pp. -. DOI: 10.1016/j.diabet.2023.101426

• 4、Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate

  Author: Niu, Jingya; Zhang, Xiaoyun; Li, Mian; Wu, Shujing; Zheng, Ruizhi; Chen, Li; Huo, Yanan; Xu, Min; Wang, Tiange; Zhao, Zhiyun; Wang, Shuangyuan; Lin, Hong; Qin, Guijun; Yan, Li; Wan, Qin; Chen, Lulu; Shi, Lixin; Hu, Ruying; Tang, Xulei; Su, Qing; Yu, Xuefeng; Qin, Yingfen; Chen, Gang; Gao, Zhengnan; Wang, Guixia; Shen, Feixia; Luo, Zuojie; Chen, Yuhong; Zhang, Yinfei; Liu, Chao; Wang, Youmin; Wu, Shengli; Yang, Tao; Li, Qiang; Mu, Yiming; Zhao, Jiajun; Bi, Yufang; Ning, Guang; Wang, Weiqing; Lu, Jieli; Xu, Yu

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2023.101420

• 5、Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

  Author: Karasik, Avraham; Lanzinger, Stefanie; Tan, Elise Chia -Hui; Yabe, Daisuke; Kim, Dae Jung; Sheu, Wayne H. -H; Melzer-Cohen, Cheli; Holl, Reinhard W.; Ha, Kyoung Hwa; Khunti, Kamlesh; Zaccardi, Francesco; Subramanian, Anuradhaa; Nirantharakumar, Krishnarajah; Nystrom, Thomas; Niskanen, Leo; Jensen, Majken Linnemann; Hoti, Fabian; Klements, Riho; Deruaz-Luyet, Anouk; Kyaw, Moe H.; Koeneman, Lisette; Vistisen, Dorte; Carstensen, Bendix; Halvorsen, Sigrun; Langslet, Gisle; Farsani, Soulmaz Fazeli; Patorno, Elisabetta; Nunez, Julio

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2022.101418

• 6、Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis

  Author: Fang, Da; Yin, Hongli; Ji, Xinlu; Sun, Haixiang; Zhao, Xiaoyu; Bi, Yan; Gu, Tianwei

  Journal: DIABETES & METABOLISM. 2023; Vol. 49, Issue 2, pp. -. DOI: 10.1016/j.diabet.2022.101397

• 7、Coexistence of hyperuricaemia and low urinary uric acid excretion further increases risk of chronic kidney disease in type 2 diabetes

  Author: Ming-Yun Chen, Ai-Ping Wang, Jun-Wei Wang, Jiang-Feng Ke, Tian-Pei Yu, Lian-Xi Li, Wei-Ping Jia

  Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.03.001

• 8、Risk of bone fracture associated with sodium–glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials

  Author: L. Cheng, Y.-Y. Li, W. Hu, F. Bai, H.-R. Hao, W.-N. Yu, X.-M. Mao

  Journal: DIABETES & METABOLISM, 2019, Vol., , DOI:10.1016/j.diabet.2019.01.010